Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Guanosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | TGM2 | P21980 | 1/20 | 0.66 |
| ▸ | HINT1 | P49773 | 4/20 | 0.64 |
| ▸ | PNP | P00491 | 1/20 | 0.61 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.61 |
| ▸ | KRAS | P01116 | 4/20 | 0.60 |
| ▸ | GSK3A | P49840 | 2/20 | 0.60 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.60 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.60 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL31361372 | 1.00 | NT5E (0.72) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL94793 | 1.00 | NT5E (0.72) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL1304255 | 1.00 | NT5E (0.72) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL376138 | 1.00 | NT5E (0.72) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL2589323 | 1.00 | NT5E (0.72) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL8719176 | 0.99 | NT5E (0.70) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL29220760 | 0.97 | NT5E (0.68) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL5356557 | 0.97 | NT5E (0.70) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL9238739 | 0.96 | NT5E (0.69) | NT5EHPGDTGM2HINT1PNP | |
| Guanosine SCHEMBL1444901 | 0.96 | NT5E (0.69) | NT5EHPGDTGM2HINT1PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15320 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026098772-A1 | SINGLE-POT IN VITRO TRANSCRIPTION OF SYNTHETIC CAPPED MRNA | ANEMOCYTE S.R.L. (IT) | 2026-05-15 | — | — | WO | claimed |
| WO-2026099317-A2 | SINGLE-POT IN VITRO TRANSCRIPTION OF SYNTHETIC CAPPED MRNA | ANEMOCYTE S.R.L. (IT) | 2026-05-15 | — | — | WO | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20260117271-A1 | SPECTRAL MONITORING OF IN VITRO TRANSCRIPTION | SANOFI PASTEUR INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4722361-A1 | VECTOR USED FOR PREPARING CIRCULAR RNA AND METHOD | Nanjing GenScript Biotech Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-20260076917-A1 | COMPOSITION AND PROCESS FOR A LIPID NANO-PARTICLE DELIVERY OF OXYGEN AND VITAL METABOLIC COMPOUNDS FOR HEMORRHAGIC SHOCK | KALOCYTE INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260072030-A1 | RAS BIOSENSORS | UNIV CALIFORNIA (US) | 2026-03-12 | — | — | US | claimed |
| US-20260062439-A1 | Enzymatic RNA Capping Method | NEW ENGLAND BIOLABS, INC. (US) | 2026-03-05 | — | — | US | claimed |
| US-20260062438-A1 | Enzymatic RNA Capping Method | NEW ENGLAND BIOLABS, INC. (US) | 2026-03-05 | — | — | US | claimed |
| WO-1991014699-A1 | SITE SPECIFIC CLEAVAGE OF SINGLE-STRANDED DNA | THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) | 1991-10-03 | — | — | WO | claimed |
| WO-1990010234-A1 | METHOD AND KIT FOR DETERMINING TYROSINE-PHOSPHORYLATING AND DEPHOSPHORYLATING ACTIVITIES | EURO-DIAGNOSTICS B.V. (NL) | 1990-09-07 | — | — | WO | claimed |
| US-4826824-A | Method of enhancing the taste perception of sweetness of aspartame and derivatives thereof | DUKE UNIVERSITY (US) | 1989-05-02 | — | — | US | claimed |
| US-4806415-A | COLORIMETRIC ANALYSIS OF GENERATED ENZYME | MILES INC. (US) | 1989-02-21 | — | — | US | claimed |
| US-4575498-A | 5-AMINO-4-IMIDAZOLE CARBOXAMIDE RIBOSIDE | DUKE UNIVERSITY (US) | 1986-03-11 | — | — | US | claimed |
| EP-0073628-B1 | LIGHT-SENSITIVE COMPOSITIONS USING RHODOPSIN AND LIGHT-ACTIVATABLE ENZYMES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-02-20 | — | — | EP | claimed |
| EP-0073628-A1 | Light-sensitive compositions using rhodopsin and light-activatable enzymes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-03-09 | — | — | EP | claimed |
| US-4356256-A | Photographic compositions, elements and processes using light-activatable enzymes | EASTMAN KODAK CO. (US) | 1982-10-26 | — | — | US | claimed |
| US-4318980-A | Heterogenous specific binding assay employing a cycling reactant as label | MILES LABORATORIES, INC. (US) | 1982-03-09 | — | — | US | claimed |
| US-4046879-A | TOPICAL | BOEHRINGER INGELHEIM GMBH (DT) | 1977-09-06 | — | — | US | claimed |